Advertisement

Topics

Gilead taps into machine learning to find new NASH drugs

05:14 EDT 16 Apr 2019 | BioPharmaDive

A three-year research deal between Gilead and California-based Insitro aims to create disease models and discover targets for the fatty liver disease.

Original Article: Gilead taps into machine learning to find new NASH drugs

NEXT ARTICLE

More From BioPortfolio on "Gilead taps into machine learning to find new NASH drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...